BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 241 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | -100.0% | 2,400 | -63.6% | 0.00% | – |
| Q3 2022 | $1,000 | -93.8% | 6,600 | -34.3% | 0.00% | -100.0% |
| Q2 2022 | $16,000 | -89.5% | 10,043 | -74.0% | 0.00% | -87.5% |
| Q1 2022 | $153,000 | +62.8% | 38,590 | +76.1% | 0.01% | +100.0% |
| Q4 2021 | $94,000 | -75.6% | 21,916 | -64.6% | 0.00% | -76.5% |
| Q3 2021 | $385,000 | +151.6% | 61,860 | +101.5% | 0.02% | +142.9% |
| Q2 2021 | $153,000 | +1076.9% | 30,700 | +78.5% | 0.01% | +600.0% |
| Q2 2020 | $13,000 | +44.4% | 17,200 | +251.0% | 0.00% | 0.0% |
| Q2 2019 | $9,000 | -77.5% | 4,900 | -22.2% | 0.00% | -80.0% |
| Q1 2019 | $40,000 | +150.0% | 6,300 | -71.6% | 0.01% | +150.0% |
| Q4 2018 | $16,000 | +33.3% | 22,200 | +46.1% | 0.00% | – |
| Q3 2018 | $12,000 | +200.0% | 15,200 | +985.7% | 0.00% | – |
| Q2 2018 | $4,000 | – | 1,400 | +40.0% | 0.00% | – |
| Q1 2018 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 1,000 | -96.2% | 0.00% | -100.0% |
| Q3 2017 | $50,000 | -71.6% | 26,432 | -88.5% | 0.00% | -66.7% |
| Q2 2017 | $176,000 | +60.0% | 229,492 | +89.2% | 0.01% | +20.0% |
| Q1 2017 | $110,000 | -56.7% | 121,272 | -12.3% | 0.01% | -44.4% |
| Q4 2016 | $254,000 | +206.0% | 138,300 | +84.2% | 0.01% | +125.0% |
| Q3 2016 | $83,000 | -24.5% | 75,100 | -14.1% | 0.00% | -20.0% |
| Q2 2016 | $110,000 | -1.8% | 87,426 | -0.7% | 0.01% | -28.6% |
| Q1 2016 | $112,000 | -56.9% | 88,026 | -17.4% | 0.01% | -50.0% |
| Q4 2015 | $260,000 | – | 106,526 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |